Review: Targeting the Transforming Growth Factor-Beta Pathway in Ovarian Cancer

Despite extensive efforts, there has been limited progress in optimizing treatment of ovarian cancer patients. The vast majority of patients experience recurrence within a few years despite a high response rate to upfront therapy. The minimal improvement in overall survival of ovarian cancer patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Roane, Brandon M., Arend, Rebecca C., Birrer, Michael J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6562901/
https://www.ncbi.nlm.nih.gov/pubmed/31091744
http://dx.doi.org/10.3390/cancers11050668

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6562901/
https://www.ncbi.nlm.nih.gov/pubmed/31091744
http://dx.doi.org/10.3390/cancers11050668

Ejemplares similares